Nasdaq · CIK 0002145089
WWB WINDWARD BIO GROUP AG
Insider trading from SEC Form 4. Last filing 14 h ago. Close $22.64 on Nov 18, 2026, 0% from the 52-week low and -25% from the high.
In brief
WINDWARD BIO GROUP AG (WWB) has 6 SEC Form 4 filings on file from 4 insiders, the latest filed on Nov 18, 2026. In the last 90 days insiders made 3 open-market buys worth $70M and 0 open-market sells worth $0, net +$70M.
3 open-market trades have been scored at WWB. The newest: David P Bonita (director and 10% owner) bought $20M of stock on Nov 16, 2026, filed Nov 18, 2026, with a score that opens a week after filing. The largest of the 3 shown: Otello Stampacchia (director) bought $30M on Nov 16, 2026, with a score that opens a week after filing. 3 insiders bought within 14 days of each other around Nov 16, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at WINDWARD BIO GROUP AG, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| Pro nowfree Nov 25, 2026 | David P Bonita Director and 10% owner buy | $20M 1,176,471 shares | +221% | - | |
| Pro nowfree Nov 25, 2026 | Orbimed Advisors LLC Director and 10% owner buy | $20M 1,176,471 shares | +221% | - | |
| Pro nowfree Nov 25, 2026 | Otello Stampacchia Director buy | $30M 1,750,000 shares | - | - |
Transactions
Every row filed, 29 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | David P Bonita Director and 10% owner | POpen-market purchase Common Sharesindirect: See footnotes | +1,176,471 | $17.00 | $20M | 1,708,103 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | CConversion Common Sharesindirect: See footnotes | +3,561,936 | - | - | 5,270,039 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | CConversion Common Sharesindirect: See footnotes | +1,611,008 | - | - | 6,881,047 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | MOption exercise Common Sharesindirect: See footnotes | +216,668 | $0.02 | $4,333 | 7,097,715 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | FTax withholding Common Sharesindirect: See footnotes | -232 | $17.00 | $3,944 | 7,097,483 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | CConversion Series A Preferred Sharesderivativeindirect: See footnotes | -3,561,936 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | CConversion Series B Preferred Sharesderivativeindirect: See footnotes | -1,611,008 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | David P Bonita Director and 10% owner | MOption exercise Warrants (right to buy)derivativeindirect: See footnotes | -216,668 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | POpen-market purchase Common Sharesindirect: See footnotes | +1,176,471 | $17.00 | $20M | 1,708,103 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | CConversion Common Sharesindirect: See footnotes | +3,561,936 | - | - | 5,270,039 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | CConversion Common Sharesindirect: See footnotes | +1,611,008 | - | - | 6,881,047 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | MOption exercise Common Sharesindirect: See footnotes | +216,668 | $0.02 | $4,333 | 7,097,715 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | FTax withholding Common Sharesindirect: See footnotes | -232 | $17.00 | $3,944 | 7,097,483 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | CConversion Series A Preferred Sharesderivativeindirect: See footnotes | -3,561,936 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | CConversion Series B Preferred Sharesderivativeindirect: See footnotes | -1,611,008 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | Orbimed Advisors LLC Director and 10% owner | MOption exercise Warrants (right to buy)derivativeindirect: See footnotes | -216,668 | $0.00 | $0 | 0 | 14 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | POpen-market purchase Common Sharesindirect: By Omega Fund VII, L.P. | +875,000 | $17.00 | $15M | 875,000 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | POpen-market purchase Common Sharesindirect: By Omega Fund VIII, L.P. | +875,000 | $17.00 | $15M | 875,000 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Common Sharesindirect: By Omega Fund VII, L.P. | +1,262,628 | - | - | 2,137,628 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Common Sharesindirect: By Omega Fund VIII, L.P. | +1,262,626 | - | - | 2,137,626 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Common Sharesindirect: By Omega Fund VII, L.P. | +531,632 | - | - | 2,669,260 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Common Sharesindirect: By Omega Fund VIII, L.P. | +531,634 | - | - | 2,669,260 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Series A Preferred Sharesderivativeindirect: By Omega Fund VII, L.P. | -1,262,628 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Series A Preferred Sharesderivativeindirect: By Omega Fund VIII, L.P. | -1,262,626 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Series B Preferred Sharesderivativeindirect: By Omega Fund VII, L.P. | -531,632 | $0.00 | $0 | 0 | 15 h ago |
| Nov 16, 2026 | Otello Stampacchia Director | CConversion Series B Preferred Sharesderivativeindirect: By Omega Fund VIII, L.P. | -531,634 | $0.00 | $0 | 0 | 15 h ago |
| Nov 12, 2026 | Iqbal Rasool Mufti Director | AGrant or award Share Option (right to buy)derivative | +22,675 | $0.00 | $0 | 22,675 | 3 d ago |
| Nov 12, 2026 | Otello Stampacchia Director | AGrant or award Share Option (right to buy)derivative | +22,675 | $0.00 | $0 | 22,675 | 3 d ago |
| Nov 12, 2026 | David P Bonita Director | AGrant or award Stock Option (right to buy)derivative | +22,675 | $0.00 | $0 | 22,675 | 3 d ago |
Insiders
Everyone who has filed a Form 4 here.
- David P Bonitadirector, owner
- Iqbal Rasool Muftidirector
- Orbimed Advisors LLCdirector, owner
- Otello Stampacchiadirector, owner, other, ceo, officer
Questions about WWB
Answered from the filings on this page, as of the latest one.
Are insiders buying WWB?
As of Nov 18, 2026, SEC Form 4 filings show 3 open-market buys worth $70M by 3 insiders and 0 open-market sells worth $0 by 0 insiders at WINDWARD BIO GROUP AG in the last 90 days, net +$70M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade WWB on the open market?
David P Bonita (director and 10% owner) bought $20M of WWB on Nov 16, 2026 and filed the Form 4 on Nov 18, 2026. InsiderTell with a score that opens a week after filing, with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at WINDWARD BIO GROUP AG?
4 people have filed a Form 4 at WINDWARD BIO GROUP AG, among them David P Bonita (director and 10% owner), Iqbal Rasool Mufti (director), Orbimed Advisors LLC (director and 10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.